Reduceddose Rivaroxaban May Be An Option After Laa Occlusion Adrift Hints | Latest News RSS feed

Reduceddose Rivaroxaban May Be An Option After Laa Occlusion Adrift Hints - Latest News


Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

PARIS, France—To head off the risk of device-related thrombus after left atrial appendage (LAA) occlusion, a reduced dose of rivaroxaban may be a viable alternative to dual antiplatelet therapy (DAPT) ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us